(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Monday.
----------
AIM - WINNERS
----------
Elixirr International PLC, up 20% at 503.0 pence, 12-month range 412p-780p. The consultancy firm says 2022 was a strong year, with all metrics to be "in line or above" market expectations. Revenue is expected to rise 40% to GBP70.7 million, within previous guidance, and adjusted earnings before interest, tax, depreciation and amortisation is expected at GBP20.4 million - which is in line with Elixirr's guidance of exceeding GBP20 million. Says 2023 has started "strongly" with an acceleration of organic growth in the first quarter, and January seeing record monthly revenue.
----------
Directa Plus PLC, up 10% at 87p, 12-month range 76p-87p. The graphene nanoplatelet products producer and supplier says revenue in 2022 is now expected at not less than EUR10.8 million, which is up from EUR10.0 million communicated back in December's trading update. This represents a 25% increase year-on-year. Says momentum has continued into 2023, with trading meeting market expectations, which Directa cites as revenue of EUR13.5 million for the year.
----------
AIM - LOSERS
----------
Hercules Site Services PLC, down 38% at 44.99p, 12-month range 40p-73p. The labour supply company for the UK infrastructure sector raises GBP1.7 million in a placing of 3.8 million shares at issue price of 45p - which represents a 24% discount to Friday's closing price of 59p. "With a strong 2023 pipeline in place, these funds will support further organic growth in our Labour Supply division, which represented over 67% of our revenue in 2022," says Chief Executive Brusk Korkmaz.
----------
Oncimmune Holdings PLC, down 23% at 42p, 12-month range 36.69p-146.0p. The immuno-diagnostics developer says, in the 15 months to August 31, revenue was GBP3.8 million, little changed from GBP3.7 million in the year to May 31. Pretax loss widens to GBP11.6 million from GBP6.1 million across the same time frame. However, says revenue in the first six months of financial 2023 are expected to exceed GBP3.8 million, and it expects to be operating cashflow positive during the year.
----------
Forward Partners Group PLC, down 6.5% at 36p, 12-month range 35p-98.4p. The early-stage technology-focused investor says the fair value of its portfolio fell 40% to no less than GBP79.0 million at December 31, from GBP117.1 million a year before. Net asset value per share is expected to plunge to 71.0p from 104p a year before. The investment firm blamed valuation headwinds, "due to public market and macroeconomic pressures". "Despite the pressure on valuations many of them still grew rapidly," says Chief Executive Nic Brisbourne.
----------
By Elizabeth Winter, Alliance News senior markets reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.
Elixirr International (ELIX)
Directa Plus (DCTA)
Hercules Site (HERC)
Oncimmune (ONC)